Company Overview and News

0
JSW energy seeks shareholders nod to raise Rs 15K Cr

2018-07-16 moneycontrol
JSW Energy said it will seek shareholders' approval to raise Rs 15,000 crore through issuance of debentures, shares and bonds at its annual general meeting on August 6.
JSWENERGY 533148

0
JSW Energy Limited - Shareholders meeting

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
JSWENERGY 533148

0
Sajjan Jindal-owned South West Mining bags iron ore mine in Jharkhand

2018-07-04 moneycontrol
South West Mining, owned by JSW Group Chairman and MD Sajjan Jindal, has won an iron ore mine in Jharkhand, auctioned last week. Situated in the state’s Bhangaon region, the mine has reserves of 40 million tonnes.
500228 JSWSTEEL JSWENERGY 533148

0
JSW Energy Limited - Acquisition

2018-06-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
JSWENERGY 533148

0
JSW Energy (₹64.3): Sell

2018-06-27 premium.thehindubusinessline
The outlook for the stock of JSW Energy is bearish. The stock, which has been falling consistently over the last one week, tumbled 4.8 per cent on Wednesday. It has plummeted about 12 per cent over the last week.
JSWENERGY 533148

9
Sanjay Sharma resigns as head of Deutsche Bank’s i-banking unit

2018-06-18 livemint
Mumbai: Sanjay Sharma, managing director and head of equity capital markets at Deutsche Bank’s Indian investment banking unit, has resigned, two people aware of the development said.
DB BHRYY 534816 INFRATEL CLNDY 533278 COALINDIA JSWENERGY 533148

12
JSW Energy, Adani Power submit EoIs for bankrupt Monnet Power

2018-06-17 livemint
Mumbai: JSW Energy and Adani Power have submitted expressions of interest (EoIs) for bankrupt Monnet Power, two people aware of the development told Mint. Monnet Power is the second of Sandeep Jajodia’s companies to undergo insolvency proceedings. Monnet Power Co. Ltd was incorporated in 2007 for setting up a thermal power plant of 1,050 megawatts (MW), backed by a pit head captive coal mine in Angul, Odisha.
500116 500228 IBN 533096 IDBI MONNETIN 532505 JSWENERGY JSWSTEEL 533148 ICICIBANK 532078 PNJZY 532461 532174 PNB ADANIPOWER UCOBANK SBAZ

12
JSW Energy submits EoI for Bhushan Energy’s assets

2018-06-06 livemint
Mumbai: Sajjan Jindal-promoted JSW Energy has expressed interest in bidding for stressed assets of Bhushan Energy, the third among the Singhal family’s debt-laden companies that have been admitted in the bankruptcy court.
500470 TTST TATASTEEL TATLY 500228 BHUSANSTL JSWSTEEL 500055 JSWENERGY SBAZ 533148

0
JSW Energy Limited - Disclosure under SEBI Takeover Regulations

2018-06-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
JSWENERGY 533148

0
JSW Energy Limited - Disclosure under SEBI Takeover Regulations

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
JSWENERGY 533148

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

21h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

23h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...